0001127602-21-012232.txt : 20210329
0001127602-21-012232.hdr.sgml : 20210329
20210329163748
ACCESSION NUMBER: 0001127602-21-012232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210325
FILED AS OF DATE: 20210329
DATE AS OF CHANGE: 20210329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARCUS JOEL S
CENTRAL INDEX KEY: 0001216955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 21782154
MAIL ADDRESS:
STREET 1: C/O ALEXANDRIA REAL ESTATE EQUITIES, INC
STREET 2: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-03-25
0001703647
Frequency Therapeutics, Inc.
FREQ
0001216955
MARCUS JOEL S
C/O FREQUENCY THERAPEUTICS, INC.,
19 PRESIDENTIAL WAY, 2ND FLOOR
WOBURN
MA
01801
1
Common Stock
2021-03-25
4
M
0
37116
3.37
A
307116
D
Common Stock
1011730
I
Alexandria Venture Investments, LLC
Stock Option
3.37
2021-03-25
4
M
0
37116
0
D
2029-05-19
Common Stock
37116
0
D
Represents securities held of record by Alexandria Venture Investments, LLC ("Alexandria"). Alexandria Real Estate Equities, Inc. is the managing member of Alexandria. Each of Alexandria and Alexandria Real Estate Equities, Inc. has shared voting and investment power with respect to the shares owned by Alexandria. The reporting person is the Executive Chairman of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria. Each of the reporting person and Alexandria Real Estate Equities, Inc. disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
The option became fully vested and exercisable on December 26, 2020.
/s/ Michael D. Bookman, Attorney-in-Fact for Joel S. Marcus
2021-03-29